Intercept Announces Positive Data in Fibrosis due to NASH Alış

Açıklama

⋅ 7 Tem 2022 17:47

ICPT: Intercept Pharmaceuticals, Inc.
2022-07-07 07:30:00
Intercept Announces Positive Data in Fibrosis due to NASH from a New Analysis of its Phase 3 REGENERATE Study of Obeticholic Acid (OCA)

Beyond Technical Analysis

Daha Fazla